Skip to main navigation
  Menu

ASLAN Pharmaceuticals

  • Pipeline
  • Our Team
  • Investor Relations
  • News & Publications
  • Contact
EN
english中文

Investor Relations

Investor Relations

  • Investor Home
  • Corporate Information
  • Stock Information
  • News & Events
  • Financial Information
  • Shareholder Services

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Alerts sign up

Required fields denoted by an asterisk ().
Alert type
Image CAPTCHA
Enter the characters shown in the image.
Get new captcha!

6-K

SEC Filing Details

Document Details

Form
6-K
Filing Date
Aug 3, 2020
Document Date
Aug 3, 2020
Form Description
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Group
Current Reports
Company
ASLAN Pharmaceuticals
Issuer
ASLAN Pharmaceuticals Ltd

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Shareholder Tools

  • Print Page

    Print Page

  • RSS Feeds

    RSS Feeds

  • E-mail Alerts

    E-mail Alerts

Company

  • Pipeline
  • Our Team
  • Investor Relations
  • News & Publications
  • Contact
  • Terms and Conditions

Careers

ASLAN is always interested in hearing from outstanding candidates with a track record in developing innovative drugs, an entrepreneurial spirit and a passion for Asia.

For more information on employment opportunities at ASLAN, please contact us at careers@aslanpharma.com

Contact Us

Singapore Headquarters
83 Clemenceau Avenue
#12-03 UE Square
Singapore 239920
Tel: +65 6222 4235
Fax: +65 6225 2419

Taipei Office
Room 3711-15, 37F,
Taipei Nanshan Plaza, No.100,
Songren Rd, Xinyi District,
Taipei 110, Taiwan (R.O.C)
Tel: +886 2 3725 7770
Fax: +886 2 3725 7999
Investor relations Tel: +886 2 3725 7768

Shanghai Office
Room 1902 Jin Hang Tower,
No.83 Wan Hang Du Road,
Jing An District, Shanghai, China, 200040
Tel: +86 138 1707 7567
Fax: +86 21 6135 9428

Australia Office
58 Gipps Street, Collingwood
Victoria, 3066

contact@aslanpharma.com